NCT05489926 2024-01-26A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor ExposureZhejiang Cancer HospitalPhase 2 Unknown15 enrolled
NCT05669768 2023-01-03Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance TherapySun Yat-sen UniversityPhase 2 Unknown46 enrolled